BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6180672)

  • 1. Leukocyte interferon in patients with juvenile laryngeal papillomatosis.
    Goepfert H; Sessions RB; Gutterman JU; Cangir A; Dichtel WJ; Sulek M
    Ann Otol Rhinol Laryngol; 1982; 91(4 Pt 1):431-6. PubMed ID: 6180672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon therapy in juvenile laryngeal papillomatosis.
    Haglund S; Lundquist PG; Cantell K; Strander H
    Arch Otolaryngol; 1981 Jun; 107(6):327-32. PubMed ID: 6164359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interferon for the treatment of juvenile papillomatosis of the larynx].
    Schouten TJ; Bos JH
    Ned Tijdschr Geneeskd; 1980 Sep; 124(39):1650-1. PubMed ID: 6158000
    [No Abstract]   [Full Text] [Related]  

  • 4. Further observations on the treatment of recurrent respiratory papillomatosis with interferon: a comparison of sources.
    Sessions RB; Goepfert H; Donovan DT; Dichtel WJ; Gutterman JU
    Ann Otol Rhinol Laryngol; 1983; 92(5 Pt 1):456-61. PubMed ID: 6194728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of human fibroblast and leukocyte interferon in the treatment of severe laryngeal papillomatosis in children.
    Göbel U; Arnold W; Wahn V; Treuner J; Jürgens H; Cantell K
    Eur J Pediatr; 1981 Oct; 137(2):175-6. PubMed ID: 6171428
    [No Abstract]   [Full Text] [Related]  

  • 6. [Juvenile laryngeal papillomatosis--a case report].
    Gappa M; Freihorst J; Seidenberg J; Vollrath M; von der Hardt H
    Pneumologie; 1991 Nov; 45(11):936-8. PubMed ID: 1763007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of juvenile papillomatosis of the larynx using interferon and levamisole].
    Klacanský I; Jakubíková J; Borecký L; Fuchsberger N
    Cesk Otolaryngol; 1986 Sep; 35(5):273-7. PubMed ID: 2428535
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon therapy in juvenile laryngeal papillomatosis.
    Lundquist PG; Haglund S; Carlsöö B; Strander H; Lundgren E
    Otolaryngol Head Neck Surg; 1984 Aug; 92(4):386-91. PubMed ID: 6207477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Juvenile laryngeal papillomatosis with two types of interferon.
    Schouten TJ; Weimar W; Bos JH; Bos CE; Cremers CW; Schellekens H
    Laryngoscope; 1982 Jun; 92(6 Pt 1):686-8. PubMed ID: 6177993
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon and laryngeal papillomatosis. The Iowa experience.
    McCabe BF; Clark KF
    Ann Otol Rhinol Laryngol; 1983; 92(1 Pt 1):2-7. PubMed ID: 6824274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laryngeal Papillomatosis: A Statistical Analysis of 60 Cases].
    Kurita T; Umeno H; Chitose S; Ueda Y; Mihashi R; Nakashima T
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Mar; 118(3):192-200. PubMed ID: 26349334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of immunocompetency in juvenile laryngeal papillomatosis.
    Perrick D; Wray BB; Leffell MS; Harmon JD; Porubsky ES
    Ann Allergy; 1990 Jul; 65(1):69-72. PubMed ID: 2368934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferons and bronchogenic carcinoma in juvenile laryngeal papillomatosis.
    Schouten TJ; van den Broek P; Cremers CW; Jongerius CM; Meyer JW; Vooys GP
    Arch Otolaryngol; 1983 May; 109(5):289-91. PubMed ID: 6189474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis.
    Avidano MA; Singleton GT
    Otolaryngol Head Neck Surg; 1995 Feb; 112(2):197-202. PubMed ID: 7530830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of human papilloma virus types on course of juvenile respiratory papillomatosis and effectiveness of interferon therapy in children].
    Nurmukhametov RKh; Onufrieva EK; Soldatskiĭ IuL; Brodskiĭ MIu
    Vestn Otorinolaringol; 2000; (2):37-40. PubMed ID: 10771610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of treatment with alpha-interferon in adult-onset laryngeal papillomatosis.
    Schuurman AM; Van Den Broek P
    Clin Otolaryngol Allied Sci; 1986 Dec; 11(6):447-53. PubMed ID: 3815871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up.
    Gerein V; Rastorguev E; Gerein J; Jecker P; Pfister H
    Ann Otol Rhinol Laryngol; 2005 Jun; 114(6):463-71. PubMed ID: 16042104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment of juvenile laryngeal papillomatosis in adults with alpha-interferon].
    van Aken WG
    Ned Tijdschr Geneeskd; 1986 Mar; 130(9):417-8. PubMed ID: 3960192
    [No Abstract]   [Full Text] [Related]  

  • 19. Intralesional cidofovir in severe juvenile respiratory papillomatosis.
    Ablanedo-Terrazas Y; Soda-Merhy A; Hernández-Palestina M; Ormsby CE; Reyes-Terán G
    B-ENT; 2012; 8(3):197-202. PubMed ID: 23113383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of long-term leukocyte interferon (alpha IFN) therapy using an individually determined dose schedule in recurrent laryngeal papillomatosis].
    Gerein V; Lodemann E; Bell G; von Ilberg C; Kornhuber B
    Klin Padiatr; 1987; 199(3):224-9. PubMed ID: 3114545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.